Synergistic Tumoricidal Effects of Alpha-Lipoic Acid and Radiotherapy on Human Breast Cancer Cells via HMGB1

Purpose Radiotherapy (RT) is one of main strategies of cancer treatment. However, some cancer cells are resistant to radiation-induced cell death, including apoptosis. Therefore, alternative approaches targeting different anti-tumor mechanisms such as cell senescence are required. This study aimed t...

Full description

Saved in:
Bibliographic Details
Published inCancer research and treatment Vol. 53; no. 3; pp. 685 - 694
Main Authors Choi, Hoon Sik, Kim, Jin Hyun, Jang, Si Jung, Yun, Jeong Won, Kang, Ki Mun, Jeong, Hojin, Ha, In Bong, Jeong, Bae Kwon
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Cancer Association 01.07.2021
대한암학회
Subjects
Online AccessGet full text
ISSN1598-2998
2005-9256
2005-9256
DOI10.4143/crt.2020.1015

Cover

Abstract Purpose Radiotherapy (RT) is one of main strategies of cancer treatment. However, some cancer cells are resistant to radiation-induced cell death, including apoptosis. Therefore, alternative approaches targeting different anti-tumor mechanisms such as cell senescence are required. This study aimed to investigate the synergistic effect of alpha-lipoic acid (ALA) on radiation-induced cell death and senescence in MDA-MB-231 human breast cancer cells.Materials and Methods The cells were divided into four groups depending on the cell treatment (control, ALA, RT, and ALA+RT). Cells were analyzed for morphology, apoptotic cell death, mitochondrial reactive oxygen species, membrane potential, cellular senescence, and cell cycle.Results Our data showed that ALA significantly promoted apoptotic cell death when combined with RT, as reflected by Annexin V staining, expression of apoptosis-related factors, mitochondrial damages as well as cell morphological changes and reduction of cell numbers. In addition, ALA significantly enhanced radiation-induced cellular senescence, which was shown by increased HMGB1 expression in the cytosol fraction compared to the control, increased p53 expression compared to the control, activation of p38 as well as nuclear factor кB, and G2/M cell cycle arrest.Conclusion The current study is the first report showing a new mode of action (senescence induction) of ALA beyond apoptotic cell death in MDA-MB-231 cancer cells known to be resistant to RT.
AbstractList Purpose Radiotherapy (RT) is one of main strategies of cancer treatment. However, some cancer cells are resistant to radiation-induced cell death, including apoptosis. Therefore, alternative approaches targeting different anti-tumor mechanisms such as cell senescence are required. This study aimed to investigate the synergistic effect of alpha-lipoic acid (ALA) on radiation-induced cell death and senescence in MDA-MB-231 human breast cancer cells.Materials and Methods The cells were divided into four groups depending on the cell treatment (control, ALA, RT, and ALA+RT). Cells were analyzed for morphology, apoptotic cell death, mitochondrial reactive oxygen species, membrane potential, cellular senescence, and cell cycle.Results Our data showed that ALA significantly promoted apoptotic cell death when combined with RT, as reflected by Annexin V staining, expression of apoptosis-related factors, mitochondrial damages as well as cell morphological changes and reduction of cell numbers. In addition, ALA significantly enhanced radiation-induced cellular senescence, which was shown by increased HMGB1 expression in the cytosol fraction compared to the control, increased p53 expression compared to the control, activation of p38 as well as nuclear factor кB, and G2/M cell cycle arrest.Conclusion The current study is the first report showing a new mode of action (senescence induction) of ALA beyond apoptotic cell death in MDA-MB-231 cancer cells known to be resistant to RT.
Radiotherapy (RT) is one of main strategies of cancer treatment. However, some cancer cells are resistant to radiation-induced cell death, including apoptosis. Therefore, alternative approaches targeting different anti-tumor mechanisms such as cell senescence are required. This study aimed to investigate the synergistic effect of alpha-lipoic acid (ALA) on radiation-induced cell death and senescence in MDA-MB-231 human breast cancer cells.PURPOSERadiotherapy (RT) is one of main strategies of cancer treatment. However, some cancer cells are resistant to radiation-induced cell death, including apoptosis. Therefore, alternative approaches targeting different anti-tumor mechanisms such as cell senescence are required. This study aimed to investigate the synergistic effect of alpha-lipoic acid (ALA) on radiation-induced cell death and senescence in MDA-MB-231 human breast cancer cells.The cells were divided into four groups depending on the cell treatment (control, ALA, RT, and ALA+RT). Cells were analyzed for morphology, apoptotic cell death, mitochondrial reactive oxygen species, membrane potential, cellular senescence, and cell cycle.MATERIALS AND METHODSThe cells were divided into four groups depending on the cell treatment (control, ALA, RT, and ALA+RT). Cells were analyzed for morphology, apoptotic cell death, mitochondrial reactive oxygen species, membrane potential, cellular senescence, and cell cycle.Our data showed that ALA significantly promoted apoptotic cell death when combined with RT, as reflected by Annexin V staining, expression of apoptosis-related factors, mitochondrial damages as well as cell morphological changes and reduction of cell numbers. In addition, ALA significantly enhanced radiation-induced cellular senescence, which was shown by increased HMGB1 expression in the cytosol fraction compared to the control, increased p53 expression compared to the control, activation of p38 as well as nuclear factor кB, and G2/M cell cycle arrest.RESULTSOur data showed that ALA significantly promoted apoptotic cell death when combined with RT, as reflected by Annexin V staining, expression of apoptosis-related factors, mitochondrial damages as well as cell morphological changes and reduction of cell numbers. In addition, ALA significantly enhanced radiation-induced cellular senescence, which was shown by increased HMGB1 expression in the cytosol fraction compared to the control, increased p53 expression compared to the control, activation of p38 as well as nuclear factor кB, and G2/M cell cycle arrest.The current study is the first report showing a new mode of action (senescence induction) of ALA beyond apoptotic cell death in MDA-MB-231 cancer cells known to be resistant to RT.CONCLUSIONThe current study is the first report showing a new mode of action (senescence induction) of ALA beyond apoptotic cell death in MDA-MB-231 cancer cells known to be resistant to RT.
Radiotherapy (RT) is one of main strategies of cancer treatment. However, some cancer cells are resistant to radiation-induced cell death, including apoptosis. Therefore, alternative approaches targeting different anti-tumor mechanisms such as cell senescence are required. This study aimed to investigate the synergistic effect of alpha-lipoic acid (ALA) on radiation-induced cell death and senescence in MDA-MB-231 human breast cancer cells. The cells were divided into four groups depending on the cell treatment (control, ALA, RT, and ALA+RT). Cells were analyzed for morphology, apoptotic cell death, mitochondrial reactive oxygen species, membrane potential, cellular senescence, and cell cycle. Our data showed that ALA significantly promoted apoptotic cell death when combined with RT, as reflected by Annexin V staining, expression of apoptosis-related factors, mitochondrial damages as well as cell morphological changes and reduction of cell numbers. In addition, ALA significantly enhanced radiation-induced cellular senescence, which was shown by increased HMGB1 expression in the cytosol fraction compared to the control, increased p53 expression compared to the control, activation of p38 as well as nuclear factor кB, and G2/M cell cycle arrest. The current study is the first report showing a new mode of action (senescence induction) of ALA beyond apoptotic cell death in MDA-MB-231 cancer cells known to be resistant to RT.
Purpose Radiotherapy (RT) is one of main strategies of cancer treatment. However, some cancer cells are resistant to radiation-induced cell death, including apoptosis. Therefore, alternative approaches targeting different anti-tumor mechanisms such as cell senescence are required. This study aimed to investigate the synergistic effect of alpha-lipoic acid (ALA) on radiation-induced cell death and senescence in MDA-MB-231 human breast cancer cells. Materials and Methods The cells were divided into four groups depending on the cell treatment (control, ALA, RT, and ALA+RT). Cells were analyzed for morphology, apoptotic cell death, mitochondrial reactive oxygen species, membrane potential, cellular senescence, and cell cycle. Results Our data showed that ALA significantly promoted apoptotic cell death when combined with RT, as reflected by Annexin V staining, expression of apoptosis-related factors, mitochondrial damages as well as cell morphological changes and reduction of cell numbers. In addition, ALA significantly enhanced radiation-induced cellular senescence, which was shown by increased HMGB1 expression in the cytosol fraction compared to the control, increased p53 expression compared to the control, activation of p38 as well as nuclear factor кB, and G2/M cell cycle arrest. Conclusion The current study is the first report showing a new mode of action (senescence induction) of ALA beyond apoptotic cell death in MDA-MB-231 cancer cells known to be resistant to RT. KCI Citation Count: 0
Author Jeong, Hojin
Kim, Jin Hyun
Choi, Hoon Sik
Ha, In Bong
Jang, Si Jung
Jeong, Bae Kwon
Yun, Jeong Won
Kang, Ki Mun
AuthorAffiliation 2 Institute of Health Science, Gyeongsang National University, Jinju, Korea
3 Biomedical Research Institute, Gyeongsang National University Hospital, Jinju, Korea
4 Department of Radiation Oncology, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea
1 Department of Radiation Oncology, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Korea
AuthorAffiliation_xml – name: 1 Department of Radiation Oncology, Gyeongsang National University Changwon Hospital, Gyeongsang National University College of Medicine, Changwon, Korea
– name: 2 Institute of Health Science, Gyeongsang National University, Jinju, Korea
– name: 4 Department of Radiation Oncology, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea
– name: 3 Biomedical Research Institute, Gyeongsang National University Hospital, Jinju, Korea
Author_xml – sequence: 1
  givenname: Hoon Sik
  surname: Choi
  fullname: Choi, Hoon Sik
– sequence: 2
  givenname: Jin Hyun
  surname: Kim
  fullname: Kim, Jin Hyun
– sequence: 3
  givenname: Si Jung
  surname: Jang
  fullname: Jang, Si Jung
– sequence: 4
  givenname: Jeong Won
  surname: Yun
  fullname: Yun, Jeong Won
– sequence: 5
  givenname: Ki Mun
  surname: Kang
  fullname: Kang, Ki Mun
– sequence: 6
  givenname: Hojin
  surname: Jeong
  fullname: Jeong, Hojin
– sequence: 7
  givenname: In Bong
  surname: Ha
  fullname: Ha, In Bong
– sequence: 8
  givenname: Bae Kwon
  surname: Jeong
  fullname: Jeong, Bae Kwon
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33321563$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002738445$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNptkc9v0zAcxS20iXWFI1fkIxzS-UfsxBekrhrrpE6TRjlbjuOsZokdbGdS_3vcdUOAuPh7-H7e-8rvnYMT550B4ANGixKX9EKHtCCIoAVGmL0BM4IQKwRh_ATMMBN1QYSoz8B5jD8Q4iWt8FtwRiklmHE6A_23vTPhwcZkNdxOgw9W21b18KrrjE4R-g4u-3Gnio0dfWaWeQ2Va-G9aq1POxPUuIfewfU0KAcvg1ExwZVy2gS4Mn0f4ZNVcH17fYnfgdNO9dG8f5lz8P3r1Xa1LjZ31zer5abQJcGpqJXGomFMCFIhQjTDiCHKaZkf0jDV1RSzlqOurHBVt4SLitcCN1XZaMOxpnPw-ejrQicftZVe2ef54OVjkMv77Y0Udc4iRzAHX47sODWDabVxKahejsEOKuyflX9vnN1lnydZE4Fz2Nng04tB8D8nE5McbNT548oZP0VJygpxImhNMvrxz1u_j7zWkQF6BHTwMQbTSW2TStYfTtteYiQPpctcujyULg-lZ1Xxj-rV-P_8L-XWrBw
CitedBy_id crossref_primary_10_1007_s43450_023_00440_4
crossref_primary_10_3390_molecules26175118
crossref_primary_10_1007_s11033_024_09422_8
crossref_primary_10_1016_j_inoche_2024_112251
crossref_primary_10_3390_ijerph19095071
crossref_primary_10_1016_j_bioactmat_2024_08_014
crossref_primary_10_1016_j_jsbmb_2024_106664
crossref_primary_10_1002_ptr_7371
crossref_primary_10_1016_j_bbadis_2024_167623
crossref_primary_10_61845_agrimedical_1356667
crossref_primary_10_1007_s10787_024_01613_w
crossref_primary_10_2174_0929867330666230509162513
crossref_primary_10_1016_j_ejphar_2022_175295
crossref_primary_10_3390_ijms242317111
crossref_primary_10_3390_cancers13246278
crossref_primary_10_3390_ijms25158455
crossref_primary_10_1016_j_tibs_2024_04_002
crossref_primary_10_1007_s10238_024_01482_1
crossref_primary_10_1016_j_bcp_2022_114989
Cites_doi 10.1016/j.ijrobp.2009.12.013
10.1038/emboj.2011.69
10.18632/oncotarget.7412
10.4143/crt.2014.320
10.4161/cbt.22003
10.18632/aging.100467
10.1016/j.freeradbiomed.2013.07.024
10.1186/s13014-019-1268-2
10.18632/oncotarget.7874
10.4103/0970-9290.131142
10.4143/crt.2015.206
10.1093/nar/gkg412
10.1096/fj.201900288r
10.1159/000484629
10.5306/wjco.v9.i8.180
10.1083/jcb.201206006
10.1016/0360-3016(95)00214-8
10.1093/jnci/djq364
10.3390/biom9080356
10.1007/s00204-014-1434-0
10.1146/annurev-pathol-121808-102144
10.18632/oncotarget.20286
10.1016/j.ejphar.2020.172938
10.1089/ars.2010.3356
10.3390/antiox8110514
10.1155/2019/3643715
ContentType Journal Article
Copyright Copyright © 2021 by the Korean Cancer Association 2021
Copyright_xml – notice: Copyright © 2021 by the Korean Cancer Association 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ACYCR
DOI 10.4143/crt.2020.1015
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2005-9256
EndPage 694
ExternalDocumentID oai_kci_go_kr_ARTI_9843756
PMC8291200
33321563
10_4143_crt_2020_1015
Genre Journal Article
GrantInformation_xml – fundername: National Research Foundation of Korea
  grantid: 2017R1D1A1B03033907
GroupedDBID ---
29B
5-W
53G
8JR
9ZL
AAYXX
ABDBF
ACUHS
ACYCR
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
E3Z
EBD
EF.
F5P
HYE
OK1
RPM
TR2
C1A
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
08R
M~E
ID FETCH-LOGICAL-c421t-8ac19b559927022c5105036340362b5af8315d60f47178d26976891b74bce61c3
ISSN 1598-2998
2005-9256
IngestDate Tue Nov 21 21:41:08 EST 2023
Thu Aug 21 14:32:11 EDT 2025
Fri Jul 11 08:12:51 EDT 2025
Thu Apr 03 06:59:54 EDT 2025
Thu Apr 24 23:10:08 EDT 2025
Tue Jul 01 03:18:50 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Senescence
Breast neoplasms
Radiotherapy
Alpha-lipoic acid
Language English
License This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c421t-8ac19b559927022c5105036340362b5af8315d60f47178d26976891b74bce61c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Hoon Sik Choi and Jin Hyun Kim contributed equally to this work.
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC8291200
PMID 33321563
PQID 2470629382
PQPubID 23479
PageCount 10
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_9843756
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8291200
proquest_miscellaneous_2470629382
pubmed_primary_33321563
crossref_citationtrail_10_4143_crt_2020_1015
crossref_primary_10_4143_crt_2020_1015
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-07-01
PublicationDateYYYYMMDD 2021-07-01
PublicationDate_xml – month: 07
  year: 2021
  text: 2021-07-01
  day: 01
PublicationDecade 2020
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Cancer research and treatment
PublicationTitleAlternate Cancer Res Treat
PublicationYear 2021
Publisher Korean Cancer Association
대한암학회
Publisher_xml – name: Korean Cancer Association
– name: 대한암학회
References ref13
Guo (ref28) 2013
ref12
ref15
ref14
ref11
ref10
ref2
ref1
ref17
ref16
ref19
ref18
Suzuki (ref20) 2008
ref24
ref23
ref26
ref25
ref22
ref21
ref27
ref29
ref8
Puchsaka (ref7) 2016
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref21
  doi: 10.1016/j.ijrobp.2009.12.013
– ident: ref14
  doi: 10.1038/emboj.2011.69
– ident: ref26
  doi: 10.18632/oncotarget.7412
– ident: ref1
  doi: 10.4143/crt.2014.320
– ident: ref5
  doi: 10.4161/cbt.22003
– ident: ref18
  doi: 10.18632/aging.100467
– ident: ref25
  doi: 10.1016/j.freeradbiomed.2013.07.024
– ident: ref11
  doi: 10.1186/s13014-019-1268-2
– ident: ref10
  doi: 10.18632/oncotarget.7874
– ident: ref3
  doi: 10.4103/0970-9290.131142
– ident: ref2
  doi: 10.4143/crt.2015.206
– ident: ref22
  doi: 10.1093/nar/gkg412
– ident: ref15
  doi: 10.1096/fj.201900288r
– ident: ref24
  doi: 10.1159/000484629
– ident: ref12
  doi: 10.5306/wjco.v9.i8.180
– ident: ref16
  doi: 10.1083/jcb.201206006
– ident: ref19
  doi: 10.1016/0360-3016(95)00214-8
– start-page: 2003
  volume-title: Oxidative stress, mitochondrial damage and neurodegenerative diseases
  year: 2013
  ident: ref28
– ident: ref13
  doi: 10.1093/jnci/djq364
– ident: ref4
  doi: 10.3390/biom9080356
– ident: ref6
  doi: 10.1007/s00204-014-1434-0
– start-page: 105
  volume-title: Stress-induced premature senescence (SIPS): influence of SIPS on radiotherapy
  year: 2008
  ident: ref20
– ident: ref17
  doi: 10.1146/annurev-pathol-121808-102144
– ident: ref9
  doi: 10.18632/oncotarget.20286
– ident: ref8
  doi: 10.1016/j.ejphar.2020.172938
– start-page: 1445
  volume-title: alpha-Lipoic acid sensitizes lung cancer cells to chemotherapeutic agents and anoikis via integrin beta1/beta3 downregulation
  year: 2016
  ident: ref7
– ident: ref23
  doi: 10.1089/ars.2010.3356
– ident: ref27
  doi: 10.3390/antiox8110514
– ident: ref29
  doi: 10.1155/2019/3643715
SSID ssj0064371
Score 2.3353856
Snippet Purpose Radiotherapy (RT) is one of main strategies of cancer treatment. However, some cancer cells are resistant to radiation-induced cell death, including...
Radiotherapy (RT) is one of main strategies of cancer treatment. However, some cancer cells are resistant to radiation-induced cell death, including apoptosis....
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 685
SubjectTerms Apoptosis - drug effects
Apoptosis - radiation effects
Breast Neoplasms - pathology
Breast Neoplasms - therapy
Cell Line, Tumor
Cell Survival
Cellular Senescence - drug effects
Cellular Senescence - radiation effects
Chemoradiotherapy - methods
Female
G2 Phase Cell Cycle Checkpoints - drug effects
G2 Phase Cell Cycle Checkpoints - radiation effects
HMGB1 Protein - agonists
HMGB1 Protein - metabolism
Humans
Original
Radiation Tolerance - drug effects
Thioctic Acid - pharmacology
Thioctic Acid - therapeutic use
의학일반
Title Synergistic Tumoricidal Effects of Alpha-Lipoic Acid and Radiotherapy on Human Breast Cancer Cells via HMGB1
URI https://www.ncbi.nlm.nih.gov/pubmed/33321563
https://www.proquest.com/docview/2470629382
https://pubmed.ncbi.nlm.nih.gov/PMC8291200
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002738445
Volume 53
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Cancer Research and Treatment, 2021, 53(3), , pp.685-694
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db5swFLXSVpr2Mu172Ze8ad5LRhvAGPsRSLpsWveyduobAkO2qBmp0uSh-8f7F7vXBkKqVur2gpB9wU7OAV-be48JeeeX2gjeOkNRmNUq6UilQweGi8AThRK50Zk9-iomJ_zzaXDa6_3pRC2tV_m-_n1tXsn_oAplgCtmyf4Dsu1NoQDOAV84AsJwvBXG3y4xc89ILQ-O179Q7mNWoFDwJkgjwlxa58vsfAE2EVTbjMSsmNWpV5f4ucAu5ccYoL4aJEiE5SAp5_OLwfdZNpgcfYzdrhdbW9RCQTY3ro1YbyBk44TFAVMJG4-YipmUWCJjpkYbk4jFCoMtoCYKmeTGVjLJu3dRYxYFzcWJsR0yu2lmawJlvK0xJWA77K5peG4b_2pZyMbQqcS0PsKL7K3xhDclypxEYNZ9eSvMKLG7Wu-XpsworSov6L6khd0kqB7vhd1k-epQwsGRBPz1EgNuPbPKEWzGzCZO4MpQuiXafaZn6Y9FerZMYWryKVWS-2EgdsieF4YYUbAXxaP4sHEb8AOqFfetf4QVhMVuHGx1YsuB2qmW0-vmRldDfDs-0_F9cq-e7NDIMvcB6ZXVQ3LnqA7neETmHQLTDoFpTWC6mNIugSkSmALbaJfAdFFRQ2BqCUwtPakhMAUCU0Pgx-TkcHycTJx6-w9Hc89dOTLTrspREQ9zJj2NUwEMO-DodOVBNpW-GxRiOAX_KpSFJ8CzlsrNQ57rUrjaf0J2q0VVPiM0F6XPp2URFpzzQJdZxnWY5ZpnmZrCMNYnH5r_NNW1Nj5u0TJPYY6MEKQAQYoQYEhk0CfvW_NzKwpzk-FbAMgw4WZG9MmbBr8U3u34wS6rysX6IvV4OBTgj0uvT55aPNv2fN8Hb134fRJuId0aYIPbNdXsp9GPl55y4bl4fpvOvSB3Nw_oS7K7Wq7LV-CGr_LXNYH_AhANydA
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synergistic+Tumoricidal+Effects+of+Alpha-Lipoic+Acid+and+Radiotherapy+on+Human+Breast+Cancer+Cells+Via+HMGB1&rft.jtitle=Cancer+research+and+treatment&rft.au=%EC%B5%9C%ED%9B%88%EC%8B%9D&rft.au=%EA%B9%80%EC%A7%84%ED%98%84&rft.au=%EC%9E%A5%EC%8B%9C%EC%A0%95&rft.au=%EC%9C%A4%EC%A0%95%EC%9B%90&rft.date=2021-07-01&rft.pub=%EB%8C%80%ED%95%9C%EC%95%94%ED%95%99%ED%9A%8C&rft.issn=1598-2998&rft.eissn=2005-9256&rft.spage=685&rft.epage=694&rft_id=info:doi/10.4143%2Fcrt.2020.1015&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_9843756
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1598-2998&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1598-2998&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1598-2998&client=summon